Gene knock-down in rainbow trout embryos using antisense morpholino phosphorodiamidate oligonucleotides

Area of Science:

• Molecular Biology
• Developmental Biology
• Aquaculture

Background:

• Antisense molecules offer versatile applications in gene function studies, trait modification, and viral disease therapy.
• Gene knock-down technology is crucial for understanding gene roles and developing targeted interventions.

Purpose of the Study:

• To develop and validate a gene knock-down technique using antisense morpholino phosphorodiamidate oligonucleotides (AMOs) in transgenic rainbow trout.
• To assess the specificity, efficacy, and toxicity of AMOs for inhibiting gene expression during embryonic development.

Main Methods:

• Utilized transgenic rainbow trout expressing the green fluorescent protein (GFP) gene as a model system.
• Microinjected AMO (AtGFP-1) targeting GFP mRNA into trout blastodiscs and evaluated dose-dependent effects.
• Assessed specificity by using inverted sequence AMOs and testing against non-targeted genes (actin, lacZ).
• Analyzed protein and mRNA levels using Western blot and RT-PCR, respectively.

Main Results:

• AtGFP-1 demonstrated dose-dependent inhibition of GFP gene expression, with 10 ng identified as optimal concentration.
• Inhibition occurred specifically at the translational level, significantly reducing GFP protein without affecting mRNA levels.
• No significant toxicity or off-target effects were observed on non-targeted genes or trout embryos.
• Gene knock-down effects persisted until the hatching stage, and a second AMO (AtGFP-2) also showed inhibition.

Conclusions:

• AMOs are potent and specific tools for gene knock-down in trout embryos.
• This technology enables precise interference with gene expression during embryonic development in salmonid fish.
• Potential applications include studying gene function and disrupting gene expression in economically important fish species.